dilazep has been researched along with Hypertension, Renal in 2 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
Excerpt | Relevance | Reference |
---|---|---|
"The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis." | 7.73 | Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005) |
"The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis." | 3.73 | Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005) |
"Treatment with dilazep was continued for a period of 6 months, at the end of which the UAE was reduced form 130 +/- 52 to 46 +/- 26 microg/min (p < 0." | 2.70 | Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease. ( Ebihara, I; Koide, H; Nakamura, T; Shimada, N; Takahashi, Y; Tanaka, A; Ushiyama, C, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Satonaka, H | 1 |
Suzuki, E | 1 |
Hayakawa, H | 1 |
Nishimatsu, H | 1 |
Nagata, D | 1 |
Oba, S | 1 |
Kamijo, A | 1 |
Takeda, R | 1 |
Takahashi, M | 1 |
Yamamoto, Y | 1 |
Kimura, K | 1 |
Hirata, Y | 1 |
Nakamura, T | 1 |
Ushiyama, C | 1 |
Takahashi, Y | 1 |
Tanaka, A | 1 |
Shimada, N | 1 |
Ebihara, I | 1 |
Koide, H | 1 |
1 trial available for dilazep and Hypertension, Renal
Article | Year |
---|---|
Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease.
Topics: Albuminuria; Dilazep; Female; Humans; Hypertension, Renal; Male; Middle Aged; Polycystic Kidney, Aut | 2001 |
1 other study available for dilazep and Hypertension, Renal
Article | Year |
---|---|
Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Dilazep; Drug Ther | 2005 |